L-selectin inhibition does not reduce injury a rabbit model of transient focal cerebral ischemia

Neurological Research

Volumn 23, Issue 1, 2001, Pages 72-78

  Yenari, M A ^a   Guo Hua Sun, ^a   Kunis, D M ^a   Onley, D ^a   Vexler, V ^a  

^a STANFORD UNIVERSITY   (United States)

Author keywords

Antibody; Cerebral ischemia; Integrin; L selectin; Neutrophil; Rabbit

Indexed keywords

ANTIBODY; CD11 ANTIGEN; CD28 ANTIGEN; CELL ADHESION MOLECULE; ELASTASE; EOSIN; HEMATOXYLIN; INTEGRIN; INTERCELLULAR ADHESION MOLECULE 1; PADGEM PROTEIN; SELECTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTERIOR CEREBRAL ARTERY; ARTICLE; BRAIN INJURY; BRAIN ISCHEMIA; CELL INFILTRATION; IMMUNOHISTOCHEMISTRY; INTERNAL CAROTID ARTERY; LEUKOCYTE; NEUTROPHIL; NONHUMAN; RABBIT; REPERFUSION; STROKE;

ANIMALS; BRAIN; BRAIN ISCHEMIA; CELL MOVEMENT; DISEASE MODELS, ANIMAL; L-SELECTIN; LEUKOCYTE COUNT; MALE; NERVE DEGENERATION; NEUTROPHILS; RABBITS;

EID: 0035143607     PISSN: 01616412     EISSN: None     Source Type: Journal    
DOI: 10.1179/016164101101198154     Document Type: Article

References (48)

1. Significance of the inflammatory response in brain ischemia
2. Inflammatory mediators and stroke: New opportunities for novel therapeutics
3. Inhibition of polymorphonuclear leukocyte adherence suppresses no-reflow after focal cerebral ischemia in baboons
4. Leukocyte-endothelial cell interactions
5. Time course of ICAM-1 expression and leukocyte subset infiltration in rat forebrain ischemia
6. Upregulation of intercellular adhesion molecule 1 (ICAM-1) on brain microvascular endothelial cells in rat ischemic cortex
7. The temporal profiles of ICAM-1 protein and mRNA expression after transient MCA occlusion in the rat
8. E-selectin appears in nonischemic tissue during experimental focal cerebral ischemia
9. P-selectin and intercellular adhesion molecule-1 expression after focal brain ischemia and reperfusion
10. E-selectin in focal cerebral ischemia and reperfusion in the rat
11. The expression of P- and E-selectins in three models of middle cerebral artery occlusion
12. Monoclonal antibodies preventing leukocyte activation reduce experimental neurologic injury and enhance efficacy of thrombolytic therapy
13. Anti-intercellular adhesion molecule-1 antibody reduces ischemic cell damage after transient but not permanent middle cerebral artery occlusion in the Wistar rat
14. Anti-ICAM-1 antibody reduces ischemic cell damage after transient middle cerebral artery occlusion in the rat
15. Cerebral protection in homozygous null ICAM-1 mice after middle cerebral artery occlusion. Role of neutrophil adhesion in the pathogenesis of stroke
16. Intercellular adhesion molecule-1-deficient mice are less susceptible to cerebral ischemia-reperfusion injury
17. Anti-CD11b monoclonal antibody reduces ischemic cell damage after transient focal cerebral ischemia in rat
18. Postischemic administration of an anti-Mac-1 antibody reduces ischemic cell damage after transient middle cerebral artery occlusion in rats
19. Reduction of central nervous system ischemic injury in rabbits using leukocyte adhesion antibody treatment
20. Hu23F2G, an antibody recognizing the leukocyte CD11/CD18 integrin, reduces injury in a rabbit model of transient focal cerebral ischemia
21. CD18-mediated neutrophil recruitment contributes to the pathogenesis of reperfused but not nonreperfused stroke
22. Exacerbation of cerebral injury in mice that express the P-selectin gene: Identification of P-selectin blockade as a new target for the treatment of stroke
23. Neuronal protection in stroke by an sLex-glycosylated complement inhibitory protein
24. Reduction of ischemic brain injury by anti-P-selectin monoclonal antibody after permanent middle cerebral artery occlusion in rat
25. Antibodies against adhesion molecules reduce apoptosis after transient middle cerebral artery occlusion in rat brain
26. L-selectin and ICAM-1 mediate reperfusion injury and neutrophil adhesion in the warm ischemic mouse liver
27. The effect of anti-L-selectin (EL-246) on remote lung injury after infrarenal ischemia/ reperfusion
28. Humanized monoclonal antibody DREG-200 directed against I-selectin protects in feline myocardial reperfusion injury
29. Blockade of selectin-mediated leukocyte adhesion improves postischemic function in lamb hearts
30. Monoclonal antibody to L-selectin attenuates neutrophil accumulation and protects ischemic reperfused cat myocardium
31. L-selectin and leukocyte function in skeletal muscle reperfusion injury
32. Renal ischemic-reperfusion injury in L-selectin-deficient mice
33. Humanized anti-L-selectin monoclonal antibody DREG200 therapy in acute thromboembolic stroke
34. Superoxide anion production during reperfusion is reduced by an antineutrophil antibody after prolonged cerebral ischemia
35. IB4, a monoclonal antibody against the CD18 leukocyte adhesion protein, reduces intracranial pressure following thromboembolic stroke in the rabbit
36. Effects of moderate hypothermia on leukocyte-endothelium interaction in the rat pial microvasculature after transient middle cerebral artery occlusion
37. Intraischemic hypothermia attenuates neutrophil infiltration in the rat neocortex after focal ischemia-reperfusion injury
38. Optimal depth and duration of mild hypothermia in a focal model of transient cerebral ischemia: Effects on neurologic outcome infarct size, apoptosis, and inflammation
39. Differential lytic and agglutinating activity of the anti-Lewis(x) monoclonal antibody FC-2.15 on human polymorphonuclear neutrophils and MCF-7 breast tumor cells. In vitro and ex vivo studies
40. Role of cell adhesion molecules in brain injury after transient middle cerebral artery occlusion in the rat
41. Improved perfusion with rt-PA and hirulog in a rabbit model of embolic stroke
42. Correlation between myeloperoxidase-quantified neutrophil accumulation and ischemic brain injury in the rat. Effects of neutrophil depletion
43. Adhesive glycoproteins CD11a and CD18 are upregulated in the leukocytes from patients with ischemic stroke and transient ischemic attacks
44. Leukocyte infiltration in acute hemispheric ischemic stroke
45. Tissue plasminogen activator for acute ischemic stroke
46. Monoclonal antibody against neutrophil adhesion in experimental stroke
47. The Enlimomab Acute Stroke Trial: Final Results
48. Anti-ICAM-1 monoclonal antibody R6.5 (Enlimomab) promotes activation of neutrophils in whole blood